ESSA Pharma Inc. Stock Company Profile

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$1.79

+0.0200 (+1.13%)

At Close: Apr 17, 2025

Information

999 West Broadway, Suite 720

Vancouver BC V5Z 1K5

778-331-0962

www.essapharma.com

Industry: Biotechnology

Sector: Healthcare

Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

GOLDEN STAR

Ticker	Change	Signal Date
F FNA $12.99	0.85%	Apr 15
V VCSH $78.34	0.370%	Apr 15
F FTSM $59.85	0.117%	Apr 15
S SLQD $49.97	0.260%	Apr 15
I ISTB $48.11	0.239%	Apr 15

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by